VEGFA and neoplasm: added bevacizumab to the system, which can prevent the expression of vascular endothelial growth factor (VEGF) to stop the growth of tumor tissues.[84] Also, Johnson's lab has created a copolymer‐based injectable hydrogel that contains PTX and resiquimod to up‐regulate tumor necrosis factor TNF‐α.